Last reviewed · How we verify
NCT05763342: OFIT
A Study of Objective Fitting for Focused Multipolar Stimulation
NA trial testing The Phoenix Research System in Hearing Loss, Bilateral in 15 participants. Completed in 26 November 2025.
20 October 2025
Quick facts
| Lead sponsor | Cochlear |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 15 |
| Start date | 8 February 2024 |
| Primary completion | 20 October 2025 |
| Estimated completion | 26 November 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- The Phoenix Research System
Conditions studied
- Hearing Loss, Bilateral — all drugs for Hearing Loss, Bilateral →
Sponsor
Cochlear — full company profile →
Who can join
18 and older, any sex, with Hearing Loss, Bilateral. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this exploratory study is to trial various objective and behavioural fitting methods for potential use with Focused Multipolar Stimulation programming.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05763342
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hearing Loss, Bilateral
Currently open trials in the same condition.
- NCT06058767 — Preschool Hearing Screening · NA · recruiting
- NCT06021132 — Characterisation of Low Frequency Hearing and Vestibular Function in Patients Undergoing Cochlear Implantation · active not recruiting
- NCT04707885 — Clinical Utility of Residual Hearing in the Cochlear Implant Ear · NA · recruiting
- NCT04857255 — Technology-assisted Language Intervention (TALI) · NA · active not recruiting
Other Cochlear trials
Trials by the same sponsor.
- NCT07077070 — Investigating Electrical Categorical Loudness Scaling Using a Mobile Research App in Experienced Adult Cochlear Implant · NA · completed
- NCT07156461 — Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients · NA · completed
- NCT06338670 — Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users · NA · completed
- NCT06298396 — Investigating Stimulation Parameter and Electrode Mode Changes on Speech Perception in Experienced Adult Cochlear Implan · NA · completed
- NCT06100393 — New Algorithms to Signal Processing for Speech Enhancement in Adult Cochlear Implant Recipients. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05763342 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cochlear
- Last refreshed: 9 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05763342.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing